Malaria Therapy
Amodiaquine with SP superior to chloroquine for first-line malaria treatment
Published in Drug Week, September 5th, 2003
In a recent study in Africa, the safety and the efficacy of three potential CQ replacement regimens - AQ alone, "AQ plus sulfadoxine-pyrimethamine (SP) (AQ plus SP), and artesunate (ART) plus SP (ART plus SP)" - were evaluated "in 379 Rwandan children 6-59 months old with uncomplicated Plasmodium falciparum malaria who visited one urban/peri-urban health center and two rural health centers."
"The three treatment regimens were well-tolerated and no serious adverse effects were observed," noted C.E. Rwagacondo and coauthors working with Rwanda's National...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2003-09-05)
More Articles from Drug Week
- Antibiotic Resistance
Newly discovered inhibitors of bacterial lactamases may prevent resistance - Pain Medicine
Compound that acts on peripheral receptors may be promising treatment - Atherosclerosis
Patient enrollment completed in phase IIb CART-2 study with AGI-1067 - Breast Cancer
Trial tests treatment for postmenopausal cancer patients who relapse - Drug Development
PEDF could potentially treat a variety of angiogenesis-related disorders - Medulloblastoma
Cancer research center reports that retinoids kill childhood brain tumor cells - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
